GLP-1 receptor agonists appeared to attenuate ethanol withdrawal symptoms and craving, based on measures of anxiety-like behavior and alcohol deprivation-induced drinking (Sharma et al., 2015; Vallöf et al., 2016; Thomsen et al., 2017). This evidence concerns the gene GLP1R and Anxiety.